Feb 29 |
Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
|
Feb 23 |
Ironwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
|
Feb 17 |
Ironwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
|
Feb 16 |
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
|
Feb 16 |
Ironwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
|
Feb 16 |
Q4 2023 Ironwood Pharmaceuticals Inc Earnings Call
|
Feb 15 |
Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2023 Earnings Call Transcript
|
Feb 15 |
Top 4 Health Care Stocks You May Want To Dump In February
|
Feb 15 |
Ironwood Pharmaceuticals (IRWD) Reports Break-Even Earnings for Q4
|
Feb 15 |
Ironwood Pharmaceuticals reports mixed Q4 results; initiates FY24 outlook
|